Pediatric ID News

Levofloxacin was safe and reduced the risk for multidrug-resistant tuberculosis among children, adolescents and adults by 60% in two phase 3 trials, according to results presented at the Union World Conference on Lung Health.

NEW YORK — In her last appearance as a presenter at the Infectious Diseases in Children Symposium, Sarah S. Long, MD, gave a brief history of vaccines — and offered a warning about the dangers of undervaccination.

NEW YORK — The United States has hit a 10-year high in drug shortages, according to a presenter at the Infectious Diseases in Children Symposium.

NEW YORK — In this video from the Infectious Diseases in Children Symposium, Ashley N. Gyura, DNP, CPNP-PC, APRN, discusses the important role pediatricians and nurses play in answering families’ questions about travel medicine.

NEW YORK — In this video, Matthew Might, PhD, discusses his keynote address at the Infectious Diseases in Children Symposium on how artificial intelligence could “shift” practice in pediatric infectious diseases.

NEW YORK — In this video from the Infectious Diseases in Children Symposium, Red Book editor David W. Kimberlin, MD, talks about updates coming to the 2024 edition of the AAP’s guide for pediatric infectious diseases.

NEW YORK — In this video from the Infectious Diseases in Children Symposium, Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, discusses the importance of pediatricians adopting new pneumococcal vaccines into practice to optimize patient coverage.

NEW YORK — An expert encouraged providers to “double our efforts” to prevent congenital syphilis.

NEW YORK — The CDC this week announced the release of more than 77,000 additional doses of nirsevimab to address an ongoing shortage of the monoclonal antibody in the United States.

Measles cases rose globally by nearly 20% in 2022, and measles deaths increased by almost half, according to data published Thursday in MMWR by the CDC and WHO.